beta-alanine has been researched along with leukotriene a4 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Askonas, LJ; Kachur, JF; Liang, CD; Russell, MA; Smith, WG; Villani-Price, D | 1 |
Askonas, LJ; Ghoreishi-Haack, N; Kachur, JF; Liang, CD; Russell, MA; Smith, WG; Villani-Price, D; Won-Kim, S | 1 |
Askonas, LJ; Chen, BB; Chen, HY; Ghoreishi-Haack, NS; Gierse, JK; Harding, EI; Highkin, MK; Kachur, JF; Kim, SH; Liang, CD; Mahoney, MW; Malecha, JW; Miyashiro, JM; Penning, TD; Pyla, EY; Russell, MA; Smith, WG; Villani-Price, D; Yu, SS | 1 |
3 other study(ies) available for beta-alanine and leukotriene a4
Article | Year |
---|---|
Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
Topics: Aminopeptidases; Animals; Arachidonic Acid; beta-Alanine; Chromatography, High Pressure Liquid; Dogs; Eicosanoids; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epoxide Hydrolases; Humans; In Vitro Techniques; Ionophores; Kinetics; Leukotriene A4; Leukotriene Antagonists; Macaca mulatta; Mice; Rats; Recombinant Proteins; Species Specificity; Substrate Specificity | 2002 |
Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
Topics: Administration, Oral; Administration, Topical; Animals; Arthus Reaction; beta-Alanine; Dermatitis; Edema; Eicosanoids; Enzyme Inhibitors; Epoxide Hydrolases; Hydroxyurea; In Vitro Techniques; Leukotriene A4; Leukotriene Antagonists; Lipoxygenase Inhibitors; Mice; Peritoneum; Rats; Skin | 2002 |
Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
Topics: Administration, Oral; Animals; beta-Alanine; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Leukotriene A4; Mice; Structure-Activity Relationship | 2002 |